
OPCH Stock Forecast & Price Target
OPCH Analyst Ratings
Bulls say
Option Care Health Inc. demonstrated robust financial performance, with a gross profit of $269.0 million reflecting an 8% year-over-year growth, surpassing estimates. The chronic therapy segment showed significant expansion, exceeding 10%, indicating strong demand for its services. Additionally, the company raised its revenue guidance for 2025 to a range of $5.5 billion to $5.65 billion, projecting a 12% year-over-year increase at the midpoint, which underscores a positive outlook on future growth.
Bears say
The outlook for Option Care Health Inc. appears negative due to several financial pressures that could hinder future growth and profitability. A significant concern is the potential loss of its largest customer, which contributed 14% to 2023 revenue, posing a substantial risk to the company's overall earnings. Additionally, management highlighted challenges regarding gross margin expansion, particularly as the company shifts towards chronic therapies that traditionally yield lower margins, coupled with an anticipated gross profit headwind exceeding $20 million related to the Stelara product.
This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.
OPCH Analyst Forecast & Price Prediction
Start investing in OPCH
Order type
Buy in
Order amount
Est. shares
0 shares